PHASE 1 CLINICAL TRIAL OF A NOVEL HER2 VACCINE FOR PATIENTS WITH DCIS

$2,140,229FY2016Defense Health AgencyDOD

Mayo Clinic, Rochester MN

Investigators

PHASE 1 CLINICAL TRIAL OF A NOVEL HER2 VACCINE FOR PATIENTS WITH DCIS · GrantIndex